# Braidwell LP 13F holdings Q2 2026: $2.7 billion

Checked November 20, 2026.

Braidwell LP reported $2.7 billion in 13F securities across 86 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Caris Life Sciences Inc at $147 million, 5.4% of the reported value. Since Q1 2026 it opened 24 new positions and exited 26.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $2,703,471,368
- Positions: 86
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1920938
- Form 13F file number: 028-23075
- CRD number: 316988
- Business address: 100 Washington Blvd 2nd Floor, Stamford, CT 06902
- SEC filing: [0001420506-26-001823](https://www.sec.gov/Archives/edgar/data/1920938/000142050626001823/0001420506-26-001823-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/braidwell-lp-316988)

## Top 25 holdings by value

The largest of 86 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Caris Life Sciences Inc](https://specstream.ai/data/institutional-holders/caris-life-sciences-inc-142152107) | COM | 8,256,032 | $147.1 million | +246,585 |
| [Hinge Health Inc](https://specstream.ai/data/institutional-holders/hinge-health-inc-433313103) | CL A | 1,330,127 | $110.4 million | -124,996 |
| [Glaukos Corp](https://specstream.ai/data/institutional-holders/glaukos-corp-377322102) | COM | 591,927 | $82.7 million | -171,578 |
| [Edgewise Therapeutics Inc](https://specstream.ai/data/institutional-holders/edgewise-therapeutics-inc-28036f105) | COM | 1,996,965 | $81.1 million | -350,618 |
| [Spyre Therapeutics Inc](https://specstream.ai/data/institutional-holders/spyre-therapeutics-inc-00773j202) | COM NEW | 879,467 | $78.1 million | -53,356 |
| [Irhythm Holdings Inc](https://specstream.ai/data/institutional-holders/irhythm-holdings-inc-450056106) | COM | 654,262 | $77.8 million | +44,070 |
| [Neogenomics Inc](https://specstream.ai/data/institutional-holders/neogenomics-inc-64049m209) | COM NEW | 4,918,202 | $71.8 million | -699,200 |
| [Kodiak Sciences Inc](https://specstream.ai/data/institutional-holders/kodiak-sciences-inc-50015m109) | COM | 1,787,318 | $69.6 million | -31,347 |
| [Xenon Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/xenon-pharmaceuticals-inc-98420n105) | COM | 1,131,452 | $68.3 million | -207,000 |
| [Alphatec Hldgs Inc](https://specstream.ai/data/institutional-holders/alphatec-hldgs-inc-02081gad4) | NOTE 0.750% 3/1 (principal) | 69,121,000 | $66.2 million | +7,500,000 |
| [Monte Rosa Therapeutics Inc](https://specstream.ai/data/institutional-holders/monte-rosa-therapeutics-inc-61225m102) | COM | 2,451,562 | $59.3 million | -755,012 |
| [Dianthus Therapeutics Inc](https://specstream.ai/data/institutional-holders/dianthus-therapeutics-inc-252828108) | COM | 594,562 | $58 million | -304,802 |
| [Neurocrine Biosciences Inc](https://specstream.ai/data/institutional-holders/neurocrine-biosciences-inc-64125c109) | COM | 336,171 | $56.7 million | -315,950 |
| [Alphatec Hldgs Inc](https://specstream.ai/data/institutional-holders/alphatec-hldgs-inc-02081g201) | COM NEW | 6,531,439 | $56.5 million | +4,358,714 |
| [Generate Biomedicines Inc](https://specstream.ai/data/institutional-holders/generate-biomedicines-inc-370920100) | COM SHS | 3,283,844 | $55.4 million | -309,155 |
| [Maravai Lifesciences Hldgs I](https://specstream.ai/data/institutional-holders/maravai-lifesciences-hldgs-i-56600d107) | COM CL A | 8,702,921 | $54.3 million | -1,537,243 |
| [Krystal Biotech Inc](https://specstream.ai/data/institutional-holders/krystal-biotech-inc-501147102) | COM | 128,975 | $47.9 million | -53,450 |
| [Humana Inc](https://specstream.ai/data/institutional-holders/humana-inc-444859102) | COM | 114,500 | $45.5 million | New |
| [Thermo Fisher Scientific Inc](https://specstream.ai/data/institutional-holders/thermo-fisher-scientific-inc-883556102) | COM | 89,395 | $44.8 million | -3,520 |
| [Kymera Therapeutics Inc](https://specstream.ai/data/institutional-holders/kymera-therapeutics-inc-501575104) | COM | 378,163 | $43.4 million | +40,604 |
| [Rhythm Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/rhythm-pharmaceuticals-inc-76243j105) | COM | 381,128 | $42.3 million | +70,500 |
| [Damora Therapeutics Inc](https://specstream.ai/data/institutional-holders/damora-therapeutics-inc-36322q206) | COM NEW | 1,620,377 | $42.1 million | +725,531 |
| [Acadia Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/acadia-pharmaceuticals-inc-004225108) | COM | 1,646,399 | $41.7 million | -824,800 |
| [Brightspring Health SVCS Inc](https://specstream.ai/data/institutional-holders/brightspring-health-svcs-inc-10950a106) | COM | 596,753 | $41.6 million | -419,809 |
| [Transmedics Group Inc](https://specstream.ai/data/institutional-holders/transmedics-group-inc-89377m109) | COM | 609,715 | $40.5 million | +280,324 |

## New positions in Q2 2026

24 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Humana Inc](https://specstream.ai/data/institutional-holders/humana-inc-444859102) | COM | 114,500 | $45.5 million |
| [Maze Therapeutics Inc](https://specstream.ai/data/institutional-holders/maze-therapeutics-inc-578784100) | COM | 1,140,040 | $34 million |
| [Avalo Therapeutics Inc](https://specstream.ai/data/institutional-holders/avalo-therapeutics-inc-05338f306) | COM NEW | 1,629,182 | $30.1 million |
| [Alamar Biosciences Inc](https://specstream.ai/data/institutional-holders/alamar-biosciences-inc-010911105) | COMMON STOCK | 1,083,983 | $29.4 million |
| [Oruka Therapeutics Inc](https://specstream.ai/data/institutional-holders/oruka-therapeutics-inc-687604108) | COM | 278,164 | $26.5 million |
| [Avalyn Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/avalyn-pharmaceuticals-inc-05348y105) | COM SHS | 801,395 | $26.4 million |
| [Immunocore Hldgs PLC](https://specstream.ai/data/institutional-holders/immunocore-hldgs-plc-45258d105) | ADS | 521,327 | $16.6 million |
| [Ovid Therapeutics Inc](https://specstream.ai/data/institutional-holders/ovid-therapeutics-inc-690469101) | COM | 5,919,464 | $15.9 million |
| [Mannkind Corp](https://specstream.ai/data/institutional-holders/mannkind-corp-56400p706) | COM NEW | 3,458,429 | $14.7 million |
| [Uniqure NV](https://specstream.ai/data/institutional-holders/uniqure-nv-n90064101) | SHS | 301,652 | $13.9 million |
| [Oculis Holding AG](https://specstream.ai/data/institutional-holders/oculis-holding-ag-h5870p102) | ORDINARY SHARES | 834,183 | $11.6 million |
| [Seaport Therapeutics Inc](https://specstream.ai/data/institutional-holders/seaport-therapeutics-inc-81221k108) | COMMON STOCK | 500,000 | $10.9 million |
| [Immunic Inc](https://specstream.ai/data/institutional-holders/immunic-inc-4525ep200) | COM NEW | 645,010 | $9.9 million |
| [Quest Diagnostics Inc](https://specstream.ai/data/institutional-holders/quest-diagnostics-inc-74834l100) | COM | 43,200 | $9.2 million |
| [Adlai Nortye LTD](https://specstream.ai/data/institutional-holders/adlai-nortye-ltd-00704r109) | SPONSORED ADS | 795,214 | $9.1 million |
| [Tenax Therapeutics Inc](https://specstream.ai/data/institutional-holders/tenax-therapeutics-inc-88032l605) | COM NEW | 584,412 | $8.5 million |
| [Kardigan Inc](https://specstream.ai/data/institutional-holders/kardigan-inc-485925101) | COM | 300,000 | $7.2 million |
| [Amanat Acquisition Corp](https://specstream.ai/data/institutional-holders/amanat-acquisition-corp-g0375m101) | CL A ORD | 700,000 | $7.1 million |
| [Hemab Therapeutics Hldgs Inc](https://specstream.ai/data/institutional-holders/hemab-therapeutics-hldgs-inc-423494103) | COM SHS | 160,000 | $5.9 million |
| [GH Research PLC](https://specstream.ai/data/institutional-holders/gh-research-plc-g3855l106) | ORDINARY SHARES | 207,240 | $5.6 million |
| [Waters Corp](https://specstream.ai/data/institutional-holders/waters-corp-941848103) | COM | 14,040 | $5.3 million |
| [Research Alliance Corp III](https://specstream.ai/data/institutional-holders/research-alliance-corp-iii-g75226103) | ORD SHS CL A | 400,000 | $4.3 million |
| [Jatt II Acquisition Corp](https://specstream.ai/data/institutional-holders/jatt-ii-acquisition-corp-g50765109) | ORD SHS | 250,000 | $2.8 million |
| [Cyclerion Therapeutics Inc](https://specstream.ai/data/institutional-holders/cyclerion-therapeutics-inc-23255m204) | COM | 156,890 | $531,857 |

## Positions exited in Q2 2026

26 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then. The 25 largest are shown.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Guardant Health Inc](https://specstream.ai/data/institutional-holders/guardant-health-inc-40131mad1) | DEBT 1.250% 2/1 (principal) | 60,954,000 | $102.6 million |
| Centessa Pharmaceuticals PLC | SPONSORED ADS | 1,986,768 | $78.9 million |
| [Nuvalent Inc](https://specstream.ai/data/institutional-holders/nuvalent-inc-670703107) | COM | 700,429 | $71.8 million |
| [CG Oncology Inc](https://specstream.ai/data/institutional-holders/cg-oncology-inc-156944100) | COM | 984,783 | $66.7 million |
| [Apogee Therapeutics Inc](https://specstream.ai/data/institutional-holders/apogee-therapeutics-inc-03770n101) | COM | 478,667 | $40.3 million |
| [Penumbra Inc](https://specstream.ai/data/institutional-holders/penumbra-inc-70975l107) | COM | 105,352 | $34.6 million |
| Soleno Therapeutics Inc | COM | 959,259 | $32.1 million |
| [Illumina Inc](https://specstream.ai/data/institutional-holders/illumina-inc-452327109) | COM | 229,215 | $28.3 million |
| [Biomarin Pharmaceutical Inc](https://specstream.ai/data/institutional-holders/biomarin-pharmaceutical-inc-09061g101) | COM | 497,020 | $28.1 million |
| [Establishment Labs Hldgs Inc](https://specstream.ai/data/institutional-holders/establishment-labs-hldgs-inc-g31249108) | COM | 463,600 | $26.3 million |
| [Fulcrum Therapeutics Inc](https://specstream.ai/data/institutional-holders/fulcrum-therapeutics-inc-359616109) | COM | 3,134,922 | $24 million |
| [CVS Health Corp](https://specstream.ai/data/institutional-holders/cvs-health-corp-126650100) | COM | 290,700 | $20.9 million |
| [Tarsus Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/tarsus-pharmaceuticals-inc-87650l103) | COM | 265,715 | $18.6 million |
| Engene Holdings Inc | COM | 2,456,870 | $16.7 million |
| Zenas Biopharma Inc | NOTE 2.500% 4/0 (principal) | 13,000,000 | $13.5 million |
| [TG Therapeutics Inc](https://specstream.ai/data/institutional-holders/tg-therapeutics-inc-88322q108) | COM | 358,800 | $11.9 million |
| [Centene Corp Del](https://specstream.ai/data/institutional-holders/centene-corp-del-15135b101) | COM | 330,000 | $10.8 million |
| [Compass Therapeutics Inc](https://specstream.ai/data/institutional-holders/compass-therapeutics-inc-20454b104) | COM | 1,965,106 | $10.4 million |
| [Revolution Medicines Inc](https://specstream.ai/data/institutional-holders/revolution-medicines-inc-76155x100) | COM | 84,900 | $8.3 million |
| [Grail Inc](https://specstream.ai/data/institutional-holders/grail-inc-384747101) | COM | 142,755 | $7.4 million |
| [Denali Therapeutics Inc](https://specstream.ai/data/institutional-holders/denali-therapeutics-inc-24823r105) | COM | 296,324 | $5.7 million |
| [Harrow Inc](https://specstream.ai/data/institutional-holders/harrow-inc-415858109) | COM | 156,419 | $5.5 million |
| [Revvity Inc](https://specstream.ai/data/institutional-holders/revvity-inc-714046109) | COM | 48,400 | $4.2 million |
| [Celcuity Inc](https://specstream.ai/data/institutional-holders/celcuity-inc-15102k100) | COM | 29,198 | $3.3 million |
| [Praxis Precision Medicines I](https://specstream.ai/data/institutional-holders/praxis-precision-medicines-i-74006w207) | COM NEW | 9,976 | $3.2 million |

## Also on SpecStream

- [Braidwell LP Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1920938/000142050626001823/0001420506-26-001823-index.htm)
- [Braidwell LP investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/braidwell-lp-316988)
- [Largest 13F filers in Connecticut](https://specstream.ai/data/institutional-holdings/state/connecticut)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Stamford, Connecticut

- [IT service companies in Stamford, Connecticut](https://specstream.ai/data/businesses/it-service-companies/stamford-connecticut-united-states)
- [Real estate firms in Stamford, Connecticut](https://specstream.ai/data/businesses/real-estate-firms/stamford-connecticut-united-states)
- [Courier and delivery companies in Stamford, Connecticut](https://specstream.ai/data/businesses/courier-and-delivery-companies/stamford-connecticut-united-states)
- [IT companies in Stamford, Connecticut](https://specstream.ai/data/businesses/it-companies/stamford-connecticut-united-states)
- [Pizza restaurants in Stamford, Connecticut](https://specstream.ai/data/businesses/pizza-restaurants/stamford-connecticut-united-states)
- [Contractors in Stamford, Connecticut](https://specstream.ai/data/businesses/contractors/stamford-connecticut-united-states)
